JP2013531598A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013531598A5 JP2013531598A5 JP2013510310A JP2013510310A JP2013531598A5 JP 2013531598 A5 JP2013531598 A5 JP 2013531598A5 JP 2013510310 A JP2013510310 A JP 2013510310A JP 2013510310 A JP2013510310 A JP 2013510310A JP 2013531598 A5 JP2013531598 A5 JP 2013531598A5
- Authority
- JP
- Japan
- Prior art keywords
- lanthanum
- carbonate
- pharmaceutical composition
- dioxycarbonate
- sodium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 claims 10
- 239000008194 pharmaceutical composition Substances 0.000 claims 8
- 229910052746 lanthanum Inorganic materials 0.000 claims 7
- FZLIPJUXYLNCLC-UHFFFAOYSA-N lanthanum atom Chemical compound [La] FZLIPJUXYLNCLC-UHFFFAOYSA-N 0.000 claims 7
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims 6
- 229910052708 sodium Inorganic materials 0.000 claims 6
- 239000011734 sodium Substances 0.000 claims 6
- OXWGHYPGHKUKBP-UHFFFAOYSA-N lanthanum tetraoxolan-5-one Chemical compound C1(OOOO1)=O.[La] OXWGHYPGHKUKBP-UHFFFAOYSA-N 0.000 claims 4
- VYGHOXHBHAWHDO-UHFFFAOYSA-K lanthanum(3+);carbonate;hydroxide Chemical group [OH-].[La+3].[O-]C([O-])=O VYGHOXHBHAWHDO-UHFFFAOYSA-K 0.000 claims 4
- 230000009747 swallowing Effects 0.000 claims 4
- 229910019142 PO4 Inorganic materials 0.000 claims 3
- 239000007894 caplet Substances 0.000 claims 3
- 239000007795 chemical reaction product Substances 0.000 claims 3
- 230000001055 chewing effect Effects 0.000 claims 3
- 239000007903 gelatin capsule Substances 0.000 claims 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 claims 3
- 239000010452 phosphate Substances 0.000 claims 3
- 239000003826 tablet Substances 0.000 claims 3
- ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 claims 2
- 235000012501 ammonium carbonate Nutrition 0.000 claims 2
- 239000001099 ammonium carbonate Substances 0.000 claims 2
- 239000002775 capsule Substances 0.000 claims 2
- 208000020832 chronic kidney disease Diseases 0.000 claims 2
- 239000002552 dosage form Substances 0.000 claims 2
- NZPIUJUFIFZSPW-UHFFFAOYSA-H lanthanum carbonate Chemical class [La+3].[La+3].[O-]C([O-])=O.[O-]C([O-])=O.[O-]C([O-])=O NZPIUJUFIFZSPW-UHFFFAOYSA-H 0.000 claims 2
- 150000002604 lanthanum compounds Chemical class 0.000 claims 2
- ICAKDTKJOYSXGC-UHFFFAOYSA-K lanthanum(iii) chloride Chemical compound Cl[La](Cl)Cl ICAKDTKJOYSXGC-UHFFFAOYSA-K 0.000 claims 2
- 239000011148 porous material Substances 0.000 claims 2
- 208000024891 symptom Diseases 0.000 claims 2
- 229910017569 La2(CO3)3 Inorganic materials 0.000 claims 1
- 208000001647 Renal Insufficiency Diseases 0.000 claims 1
- 239000008280 blood Substances 0.000 claims 1
- 210000004369 blood Anatomy 0.000 claims 1
- 238000001354 calcination Methods 0.000 claims 1
- 230000001684 chronic effect Effects 0.000 claims 1
- 235000009508 confectionery Nutrition 0.000 claims 1
- 239000006185 dispersion Substances 0.000 claims 1
- 239000000839 emulsion Substances 0.000 claims 1
- 208000028208 end stage renal disease Diseases 0.000 claims 1
- 201000000523 end stage renal failure Diseases 0.000 claims 1
- 238000010304 firing Methods 0.000 claims 1
- 235000013305 food Nutrition 0.000 claims 1
- 239000000499 gel Substances 0.000 claims 1
- 201000005991 hyperphosphatemia Diseases 0.000 claims 1
- 201000006370 kidney failure Diseases 0.000 claims 1
- 229960001633 lanthanum carbonate Drugs 0.000 claims 1
- -1 lanthanum carbonate compound Chemical class 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 239000000843 powder Substances 0.000 claims 1
- 230000001376 precipitating effect Effects 0.000 claims 1
- 230000008085 renal dysfunction Effects 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 239000002904 solvent Substances 0.000 claims 1
- 239000000725 suspension Substances 0.000 claims 1
- 239000006188 syrup Substances 0.000 claims 1
- 235000020357 syrup Nutrition 0.000 claims 1
- 230000009885 systemic effect Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US33388710P | 2010-05-12 | 2010-05-12 | |
| US61/333,887 | 2010-05-12 | ||
| PCT/US2011/036317 WO2011143475A1 (en) | 2010-05-12 | 2011-05-12 | Lanthanum carbonate hydroxide, lanthanum oxycarbonate and methods of their manufacture and use |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016077533A Division JP6397845B2 (ja) | 2010-05-12 | 2016-04-07 | 炭酸ランタン水酸化物、ランタンオキシカルボネートならびにその製造および使用方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013531598A JP2013531598A (ja) | 2013-08-08 |
| JP2013531598A5 true JP2013531598A5 (enExample) | 2014-06-19 |
| JP5993368B2 JP5993368B2 (ja) | 2016-09-14 |
Family
ID=44279001
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013510310A Active JP5993368B2 (ja) | 2010-05-12 | 2011-05-12 | 炭酸ランタン水酸化物、ランタンオキシカルボネートならびにその製造および使用方法 |
| JP2016077533A Active JP6397845B2 (ja) | 2010-05-12 | 2016-04-07 | 炭酸ランタン水酸化物、ランタンオキシカルボネートならびにその製造および使用方法 |
| JP2018097513A Active JP6938425B2 (ja) | 2010-05-12 | 2018-05-22 | 炭酸ランタン水酸化物、ランタンオキシカルボネートならびにその製造および使用方法 |
| JP2021142223A Active JP7280318B2 (ja) | 2010-05-12 | 2021-09-01 | 炭酸ランタン水酸化物、ランタンオキシカルボネートならびにその製造および使用方法 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016077533A Active JP6397845B2 (ja) | 2010-05-12 | 2016-04-07 | 炭酸ランタン水酸化物、ランタンオキシカルボネートならびにその製造および使用方法 |
| JP2018097513A Active JP6938425B2 (ja) | 2010-05-12 | 2018-05-22 | 炭酸ランタン水酸化物、ランタンオキシカルボネートならびにその製造および使用方法 |
| JP2021142223A Active JP7280318B2 (ja) | 2010-05-12 | 2021-09-01 | 炭酸ランタン水酸化物、ランタンオキシカルボネートならびにその製造および使用方法 |
Country Status (16)
| Country | Link |
|---|---|
| US (5) | US8961917B2 (enExample) |
| EP (2) | EP3848040A1 (enExample) |
| JP (4) | JP5993368B2 (enExample) |
| KR (2) | KR101940207B1 (enExample) |
| CN (1) | CN103037870B (enExample) |
| AR (2) | AR081395A1 (enExample) |
| AU (1) | AU2011252983C1 (enExample) |
| BR (1) | BR112012028629B8 (enExample) |
| CA (2) | CA3224506A1 (enExample) |
| ES (1) | ES2871021T3 (enExample) |
| IL (1) | IL222824B (enExample) |
| MX (1) | MX350075B (enExample) |
| RU (1) | RU2570007C2 (enExample) |
| TW (1) | TWI446916B (enExample) |
| WO (1) | WO2011143475A1 (enExample) |
| ZA (1) | ZA201209322B (enExample) |
Families Citing this family (43)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2011252983C1 (en) * | 2010-05-12 | 2015-02-19 | Unicycive Therapeutics, Inc. | Lanthanum carbonate hydroxide, lanthanum oxycarbonate and methods of their manufacture and use |
| US9575059B2 (en) | 2012-06-05 | 2017-02-21 | 3M Innovative Properties Company | Lanthanum-based concentration agents for microorganisms |
| CA2876689C (en) | 2012-06-13 | 2022-04-26 | Incyte Corporation | Substituted tricyclic compounds as fgfr inhibitors |
| PH12015502383B1 (en) | 2013-04-19 | 2023-02-03 | Incyte Holdings Corp | Bicyclic heterocycles as fgfr inhibitors |
| CN104129810A (zh) * | 2013-05-02 | 2014-11-05 | 南京大学 | 纯单斜晶相的刺球状碳酸氧镧(La2O2CO3)三维多级结构的制备 |
| CN104592994B (zh) * | 2015-01-14 | 2018-01-02 | 惠州学院 | 一种三角枝状铕掺杂羟基碳酸镧红色荧光粉的制备方法 |
| MA41551A (fr) | 2015-02-20 | 2017-12-26 | Incyte Corp | Hétérocycles bicycliques utilisés en tant qu'inhibiteurs de fgfr4 |
| CA2976790C (en) | 2015-02-20 | 2024-02-27 | Incyte Corporation | Bicyclic heterocycles as fgfr inhibitors |
| JP6093829B1 (ja) * | 2015-10-02 | 2017-03-08 | バイエル薬品株式会社 | ランタン化合物を含む医薬組成物 |
| CN105749892B (zh) * | 2016-05-16 | 2018-02-02 | 哈尔滨工业大学 | 一种针对水体除磷的海胆状微球碳酸氧镧吸附剂的制备方法 |
| CN109314212B (zh) * | 2016-06-24 | 2022-02-08 | 日本碍子株式会社 | 包含层状双氢氧化物的功能层及复合材料 |
| CN107188215A (zh) * | 2017-05-24 | 2017-09-22 | 中国北方稀土（集团）高科技股份有限公司 | 碳酸稀土连续沉淀生产过程中自动调节反应终点的方法 |
| AR111960A1 (es) | 2017-05-26 | 2019-09-04 | Incyte Corp | Formas cristalinas de un inhibidor de fgfr y procesos para su preparación |
| RU2657755C1 (ru) * | 2017-07-10 | 2018-06-15 | Александр Александрович Кролевец | Способ получения нанокапсул солей лантаноидов в каррагинане |
| US11865509B2 (en) | 2018-01-04 | 2024-01-09 | Asahi Kasei Kabushiki Kaisha | Porous molding |
| RS66310B1 (sr) | 2018-05-04 | 2025-01-31 | Incyte Corp | Čvrsti oblici inhibitora fgfr i procesi za njegovu pripremu |
| KR102956194B1 (ko) | 2018-05-04 | 2026-04-23 | 인사이트 코포레이션 | Fgfr 억제제의 염 |
| CN111587372B (zh) * | 2018-07-13 | 2023-09-19 | 富士电机株式会社 | 二氧化碳气体传感器 |
| JP7506892B2 (ja) * | 2018-08-21 | 2024-06-27 | 東和薬品株式会社 | 化合物の特定形状の結晶及びその製造方法 |
| JP2020099866A (ja) * | 2018-12-21 | 2020-07-02 | 旭化成株式会社 | 多孔性成形体 |
| RU2693176C1 (ru) * | 2018-12-28 | 2019-07-01 | Общество С Ограниченной Ответственностью "Лаборатория Инновационных Технологий" | Способ получения карбонатов редкоземельных элементов |
| CN109490464A (zh) * | 2019-01-24 | 2019-03-19 | 内蒙古医科大学 | 一种基于离子色谱技术测定稀土药物中镧元素含量的方法 |
| WO2020185532A1 (en) | 2019-03-08 | 2020-09-17 | Incyte Corporation | Methods of treating cancer with an fgfr inhibitor |
| WO2021007269A1 (en) | 2019-07-09 | 2021-01-14 | Incyte Corporation | Bicyclic heterocycles as fgfr inhibitors |
| US12122767B2 (en) | 2019-10-01 | 2024-10-22 | Incyte Corporation | Bicyclic heterocycles as FGFR inhibitors |
| GEP20247679B (en) | 2019-10-14 | 2024-10-10 | Incyte Corp | Bicyclic heterocycles as fgfr inhibitors |
| US11566028B2 (en) | 2019-10-16 | 2023-01-31 | Incyte Corporation | Bicyclic heterocycles as FGFR inhibitors |
| MX2022006691A (es) | 2019-12-04 | 2022-09-19 | Incyte Corp | Derivados de un inhibidor de receptores del factor de crecimiento de fibroblastos (fgfr). |
| WO2021113479A1 (en) | 2019-12-04 | 2021-06-10 | Incyte Corporation | Tricyclic heterocycles as fgfr inhibitors |
| CN113029978A (zh) * | 2019-12-25 | 2021-06-25 | 远大生命科学(辽宁)有限公司 | 一种检测含镧试剂的磷结合能力的方法 |
| US12012409B2 (en) | 2020-01-15 | 2024-06-18 | Incyte Corporation | Bicyclic heterocycles as FGFR inhibitors |
| CN113019305B (zh) * | 2021-03-03 | 2021-10-15 | 重庆三峡学院 | 多孔碱式碳酸镧磷酸盐吸附剂的制备及其应用 |
| EP4323405A1 (en) | 2021-04-12 | 2024-02-21 | Incyte Corporation | Combination therapy comprising an fgfr inhibitor and a nectin-4 targeting agent |
| CN113311100A (zh) * | 2021-05-27 | 2021-08-27 | 南京诺亚药业有限公司 | 一种碳酸镧制剂中的镧含量的测定方法 |
| CA3220274A1 (en) | 2021-06-09 | 2022-12-15 | Incyte Corporation | Tricyclic heterocycles as fgfr inhibitors |
| TW202313610A (zh) | 2021-06-09 | 2023-04-01 | 美商英塞特公司 | 作為ｆｇｆｒ抑制劑之三環雜環 |
| CN115487839B (zh) * | 2021-06-17 | 2024-03-26 | 中国石油化工股份有限公司 | 片状催化剂及其制备方法和应用 |
| CN114749182A (zh) * | 2022-03-29 | 2022-07-15 | 中国科学院兰州化学物理研究所 | 一种用于甲烷干重整的镍-氧化镧催化剂及其制备方法 |
| CN116924449B (zh) * | 2022-03-29 | 2025-12-09 | 包头稀土研究院 | 碱式碳酸镧颗粒及其制备方法 |
| CN116924450B (zh) * | 2022-03-29 | 2025-09-30 | 包头稀土研究院 | 用氯化稀土料液制备碱式碳酸稀土的方法 |
| US20260014083A1 (en) * | 2022-07-01 | 2026-01-15 | Amgmt | Orally Administrable Pharmaceutical Dosage Form Comprising Lanthanum and Its Use in a Method Of Treatment of Hyperoxaluria |
| CN116809015A (zh) * | 2023-04-03 | 2023-09-29 | 中国市政工程中南设计研究总院有限公司 | 一种粘土-碳酸镧复合材料及其制备方法和应用 |
| CN121221637A (zh) * | 2025-11-27 | 2025-12-30 | 南昌大学第一附属医院 | 碳酸镧在制备抗肝硬化和抑制肝脏炎症药物中的应用 |
Family Cites Families (70)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3768989A (en) | 1968-08-19 | 1973-10-30 | N Goetzinger | Process for the preparation of a rare earth oxide polishing composition |
| US3692671A (en) | 1970-10-01 | 1972-09-19 | North American Rockwell | Rare earth ion removal from waste water |
| US3922333A (en) | 1973-06-04 | 1975-11-25 | Us Air Force | Process for preparing mullite powder and fabrication of structural bodies therefrom |
| US3922331A (en) | 1973-11-14 | 1975-11-25 | Us Interior | Preparation of microporous rare-earth oxyhalides |
| US4240048A (en) | 1978-12-15 | 1980-12-16 | E. I. Du Pont De Nemours & Co. | Nonlinear optical device |
| ATE5845T1 (de) | 1980-11-14 | 1984-02-15 | Rudolf Schanze | Fuer menschen und tiere geeignetes, spurenelemente enthaltendes konzentrat, ein verfahren zu seiner herstellung und seine verwendung. |
| US4462970A (en) | 1981-08-19 | 1984-07-31 | Hughes Aircraft Company | Process for preparation of water-free oxychloride material |
| US4497785A (en) | 1983-11-18 | 1985-02-05 | Union Oil Company Of California | Production of rare earth compounds |
| JPS60206448A (ja) | 1984-03-29 | 1985-10-18 | Nissan Motor Co Ltd | 排ガス浄化用触媒担体 |
| JPS60226414A (ja) | 1984-04-20 | 1985-11-11 | Hitachi Ltd | ランタン・アルミナ系複合酸化物の製造法 |
| JPS614529A (ja) | 1984-06-15 | 1986-01-10 | Asahi Chem Ind Co Ltd | リン酸イオンの吸着剤 |
| AU601998B2 (en) | 1985-07-11 | 1990-09-27 | Rhone-Poulenc Specialites Chimiques | Oxygenated rare earth derivatives |
| US5782792A (en) | 1986-11-21 | 1998-07-21 | Cypress Bioscience, Inc. | Method for treatment of rheumatoid arthritis |
| US4919902A (en) | 1987-09-30 | 1990-04-24 | Allied-Signal Inc. | Catalyst for treatment of exhaust gases from internal combustion engines |
| FR2623797B2 (fr) | 1987-08-05 | 1990-05-04 | Inst Francais Du Petrole | Procede de conversion du methane en hydrocarbures superieurs |
| US5234957A (en) | 1991-02-27 | 1993-08-10 | Noven Pharmaceuticals, Inc. | Compositions and methods for topical administration of pharmaceutically active agents |
| FR2634398B1 (fr) | 1988-06-29 | 1990-09-07 | Elf Aquitaine | Procede de preparation d'un catalyseur apte a promouvoir la conversion oxydante du methane en hydrocarbures superieurs |
| GB9201857D0 (en) | 1992-01-29 | 1992-03-18 | Smithkline Beecham Plc | Novel compound |
| US5407560A (en) | 1992-03-16 | 1995-04-18 | Japan Energy Corporation | Process for manufacturing petroleum cokes and cracked oil from heavy petroleum oil |
| EP0604919A1 (en) | 1992-12-28 | 1994-07-06 | Ishihara Sangyo Kaisha, Ltd. | Deodorant |
| WO1994019286A1 (en) | 1993-02-24 | 1994-09-01 | Dudley John Mills | Treatment of swimming pool water |
| US5667775A (en) | 1993-08-11 | 1997-09-16 | Geltex Pharmaceuticals, Inc. | Phosphate-binding polymers for oral administration |
| JPH0810610A (ja) | 1994-07-05 | 1996-01-16 | Ishihara Sangyo Kaisha Ltd | リン吸着剤 |
| GB9506126D0 (en) * | 1995-03-25 | 1995-05-10 | Johnson Matthey Plc | Pharmaceutical composition and method |
| US6376479B1 (en) | 1995-04-03 | 2002-04-23 | Bone Care International, Inc. | Method for treating and preventing hyperparathyroidism |
| US20020183288A1 (en) | 1995-04-03 | 2002-12-05 | Bone Care International, Inc. | Method for treating and preventing hyperparathyroidism |
| GB9611437D0 (en) | 1995-08-03 | 1996-08-07 | Secr Defence | Biomaterial |
| JP2843909B2 (ja) | 1996-05-27 | 1999-01-06 | 科学技術庁無機材質研究所長 | 酸化イットリウム透明焼結体の製造方法 |
| JP3081910B2 (ja) | 1997-08-07 | 2000-08-28 | 工業技術院長 | ヒ素（ｖ）イオンの除去方法 |
| GB9720061D0 (en) | 1997-09-19 | 1997-11-19 | Crosfield Joseph & Sons | Metal compounds as phosphate binders |
| US5843477A (en) | 1997-09-30 | 1998-12-01 | Bayer Corporation | Lubricants for use in tabletting |
| DK1067910T3 (da) | 1998-04-03 | 2004-10-04 | Egalet As | Komposition med styret afgivelse |
| US6197201B1 (en) | 1998-07-29 | 2001-03-06 | The Board Of Regents Of The University & Community College System Of Nevada | Process for removal and stabilization of arsenic and selenium from aqueous streams and slurries |
| US6312604B1 (en) | 1998-10-23 | 2001-11-06 | Zodiac Pool Care, Inc. | Lanthanide halide water treatment compositions and methods |
| DE60029628T2 (de) | 1999-12-22 | 2007-07-26 | Wisconsin Alumni Research Foundation, Madison | Calciumformiat als diätzusatz |
| US6338800B1 (en) | 2000-02-22 | 2002-01-15 | Natural Chemistry, Inc. | Methods and compositions using lanthanum for removing phosphates from water |
| US6521647B2 (en) | 2000-04-04 | 2003-02-18 | Pfizer Inc. | Treatment of renal disorders |
| GB0015745D0 (en) | 2000-06-27 | 2000-08-16 | Shire Holdings Ag | Treatment of bone diseases |
| JP3407039B2 (ja) | 2000-07-10 | 2003-05-19 | 独立行政法人産業技術総合研究所 | ヒ素汚染土壌洗浄剤並びにヒ素汚染土壌安定化剤及びこれらをを用いたヒ素汚染土壌修復方法 |
| FR2811571B1 (fr) | 2000-07-11 | 2002-10-11 | Flamel Tech Sa | Composition pharmaceutique orale, permettant la liberation controlee et l'absorption prolongee d'un principe actif |
| US6403523B1 (en) | 2000-09-18 | 2002-06-11 | Union Carbide Chemicals & Plastics Technology Corporation | Catalysts for the oxidative dehydrogenation of hydrocarbons |
| FR2820134A1 (fr) | 2001-01-29 | 2002-08-02 | Rhodia Elect & Catalysis | Oxychlorure de terre rare a surface specifique elevee, ses procedes de preparation et son utilisation comme catalyseur |
| US6849609B2 (en) | 2001-04-10 | 2005-02-01 | James U. Morrison | Method and composition for controlled release acarbose formulations |
| JP4515030B2 (ja) | 2001-04-23 | 2010-07-28 | アノーメッド インコーポレイティド | 腎臓結石疾患の予防のための希土類化合物の使用 |
| MXPA04002973A (es) | 2001-09-28 | 2005-06-20 | Johnson & Johnson | Formas de dosis de liberacion modificada. |
| US7119120B2 (en) | 2001-12-26 | 2006-10-10 | Genzyme Corporation | Phosphate transport inhibitors |
| WO2003094933A2 (en) | 2002-05-08 | 2003-11-20 | Shire Holding Ag | Use of lanthanum for the treatment of hypercalcemia and bone metastasis |
| US20040161474A1 (en) | 2002-05-24 | 2004-08-19 | Moerck Rudi E. | Rare earth metal compounds methods of making, and methods of using the same |
| US20060083791A1 (en) | 2002-05-24 | 2006-04-20 | Moerck Rudi E | Rare earth metal compounds methods of making, and methods of using the same |
| CN100526219C (zh) | 2002-08-14 | 2009-08-12 | 爱尔达纳米公司 | 稀土金属化合物、其制造方法及其使用方法 |
| MY148805A (en) | 2002-10-16 | 2013-05-31 | Takeda Pharmaceutical | Controlled release preparation |
| WO2004050558A2 (en) | 2002-12-02 | 2004-06-17 | Altair Nanomaterials Inc. | Rare earth compositions and structures for removing phosphates from water |
| JP4128906B2 (ja) * | 2003-05-15 | 2008-07-30 | 三井金属鉱業株式会社 | セリウム系研摩材及びセリウム系研摩材の製造方法 |
| DK2792363T3 (da) * | 2003-08-26 | 2016-09-26 | Shire Biopharmaceuticals Holdings Ireland Ltd | Farmaceutisk formulering, der omfatter lanthanforbindelser |
| US7381428B2 (en) | 2003-08-26 | 2008-06-03 | Shire International Licensing B.V. | Stabilized lanthanum carbonate compositions |
| JP4834953B2 (ja) | 2003-10-31 | 2011-12-14 | 富士ゼロックス株式会社 | 脂肪族ポリケトン類ポリマー及び脂肪族ポリケトン類ポリマー含有組成物の製造方法 |
| US7459502B2 (en) | 2003-11-03 | 2008-12-02 | Ilypsa, Inc. | Pharmaceutical compositions comprising crosslinked polyamine polymers |
| US20050182011A1 (en) | 2003-11-13 | 2005-08-18 | Eric Olson | Inhibition of TRP channels as a treatment for cardiac hypertrophy and heart failure |
| CN1557982A (zh) | 2004-01-19 | 2004-12-29 | 太原理工大学 | 细化阻燃复合剂及其制备方法 |
| MX2007001114A (es) | 2004-07-27 | 2007-07-11 | Shire Pharmaceuticals Inc | Metodo para tratar hiperfosfatemia usando hidroxicarbonato de lantano. |
| US20060134225A1 (en) | 2004-10-15 | 2006-06-22 | Moerck Rudi E | Phosphate binder with reduced pill burden |
| US20060177415A1 (en) | 2004-11-01 | 2006-08-10 | Burke Steven K | Once a day formulation for phosphate binders |
| EP1698233A1 (en) | 2005-03-01 | 2006-09-06 | Bayer HealthCare AG | Reduction of digestibility of phosphorus in animal nutrition |
| JP2009504423A (ja) | 2005-08-11 | 2009-02-05 | イノヴァライト インコーポレイテッド | 安定にパッシベートされたｉｖ族半導体ナノ粒子、並びにその製造方法及びその組成物 |
| WO2007022445A2 (en) | 2005-08-17 | 2007-02-22 | Altairnano, Inc. | Treatment of chronic renal failure and other conditions in domestic animals: compositions and methods |
| WO2007022466A2 (en) * | 2005-08-17 | 2007-02-22 | Altairnano, Inc. | Hyperphosphatemia in domestic animals: compositions and methods of treatment |
| US20070259052A1 (en) | 2006-05-05 | 2007-11-08 | Shire International Licensing B.V. | Assay for lanthanum hydroxycarbonate |
| CN101077338B (zh) * | 2006-05-24 | 2012-06-20 | 天津大学 | 纳米碳酸镧口腔崩解片及制备方法 |
| CN102714064B (zh) | 2009-11-06 | 2015-11-25 | 泰拉能源有限责任公司 | 核裂变行波反应堆及迁移燃料组件的系统 |
| AU2011252983C1 (en) | 2010-05-12 | 2015-02-19 | Unicycive Therapeutics, Inc. | Lanthanum carbonate hydroxide, lanthanum oxycarbonate and methods of their manufacture and use |
-
2011
- 2011-05-12 AU AU2011252983A patent/AU2011252983C1/en active Active
- 2011-05-12 RU RU2012146818/05A patent/RU2570007C2/ru active
- 2011-05-12 CN CN201180023076.0A patent/CN103037870B/zh active Active
- 2011-05-12 ES ES11721201T patent/ES2871021T3/es active Active
- 2011-05-12 EP EP21159393.4A patent/EP3848040A1/en active Pending
- 2011-05-12 JP JP2013510310A patent/JP5993368B2/ja active Active
- 2011-05-12 CA CA3224506A patent/CA3224506A1/en active Pending
- 2011-05-12 TW TW100116778A patent/TWI446916B/zh active
- 2011-05-12 WO PCT/US2011/036317 patent/WO2011143475A1/en not_active Ceased
- 2011-05-12 KR KR1020177030161A patent/KR101940207B1/ko active Active
- 2011-05-12 BR BR112012028629A patent/BR112012028629B8/pt active IP Right Grant
- 2011-05-12 KR KR1020127032038A patent/KR101830456B1/ko active Active
- 2011-05-12 MX MX2012013065A patent/MX350075B/es active IP Right Grant
- 2011-05-12 US US13/106,637 patent/US8961917B2/en active Active
- 2011-05-12 CA CA2798081A patent/CA2798081C/en active Active
- 2011-05-12 EP EP11721201.9A patent/EP2568989B1/en active Active
- 2011-05-13 AR ARP110101656A patent/AR081395A1/es active IP Right Grant
-
2012
- 2012-11-01 IL IL222824A patent/IL222824B/en active IP Right Grant
- 2012-12-10 ZA ZA2012/09322A patent/ZA201209322B/en unknown
-
2013
- 2013-12-12 US US14/104,663 patent/US10350240B2/en active Active
-
2016
- 2016-04-07 JP JP2016077533A patent/JP6397845B2/ja active Active
-
2018
- 2018-05-22 JP JP2018097513A patent/JP6938425B2/ja active Active
-
2019
- 2019-06-06 US US16/433,318 patent/US11406663B2/en active Active
-
2020
- 2020-01-10 AR ARP200100076A patent/AR117804A2/es unknown
-
2021
- 2021-09-01 JP JP2021142223A patent/JP7280318B2/ja active Active
-
2022
- 2022-07-11 US US17/861,413 patent/US20220347210A1/en not_active Abandoned
-
2025
- 2025-06-02 US US19/225,647 patent/US20250288608A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2012146818A (ru) | Гидроксид карбонат лантана, оксикарбонат лантана и способы их получения и применения | |
| TWI657826B (zh) | Complex of angiotensin II receptor antagonist metabolite and NEP inhibitor and preparation method thereof | |
| JP2022536979A5 (enExample) | ||
| JP2013519632A5 (enExample) | ||
| JP2014524442A5 (enExample) | ||
| WO2003037881A1 (en) | α-FORM OR ß-FORM CRYSTAL OF ACETANILIDE DERIVATIVE | |
| CA2984434A1 (en) | Monolithic tablets based on carboxyl polymeric complexes for controlled drug release | |
| JP2012519201A5 (enExample) | ||
| RU2011134847A (ru) | Фармацевтические композиции, содержащие фосфатсвязывающий полимер | |
| CN113286789B (zh) | 血管紧张素ii受体拮抗剂代谢产物与nep抑制剂的复合物的新用途 | |
| JP2018521121A5 (enExample) | ||
| TW201720444A (zh) | 含有2-{4-[n-(5,6-二苯基吡 -2-基)-n-異丙基胺基]丁基氧基}-n-(甲基磺醯基)乙醯胺之醫藥組合物 | |
| CN101948485B (zh) | 富马酸替诺福韦酯α晶型及其制备方法和应用 | |
| JP2015510916A5 (enExample) | ||
| JP2018526349A (ja) | 医薬品グレードのクエン酸第二鉄の調製のためのプロセス | |
| RU2017131522A (ru) | (2s,4r)-5-(5'-хлор-2'-фторбифенил-4-ил)-2-этоксиоксалиламино)-)-2-гидроксиметил-2-метилпентановая кислота | |
| WO2015110968A1 (en) | Pharmaceutical grade ferric citrate and method for its production | |
| KR20080055990A (ko) | 시나칼셋 ＨＣｌ의 결정형 및 이의 제조 방법 | |
| JP2018506535A5 (ja) | ネプリライシン阻害剤としての（２ｓ，４ｒ）−５−（５’−クロロ−２’−フルオロビフェニル−４−イル）−４−（エトキシオキサリルアミノ）−２−ヒドロキシメチル−２−メチルペンタン酸 | |
| CN108078937B (zh) | 一种铝碳酸镁片及其制备方法 | |
| CN101250183A (zh) | 一种雷贝拉唑的光学异构体及其制备方法、医药用途 | |
| JP2018193348A (ja) | 炭酸ランタンを含む口腔内崩壊錠 | |
| WO2013115746A1 (en) | A production method for (effervescent) pharmaceutical compositions comprising an alpha - glucosidase inhibitor (miglitol) and metformin | |
| WO2011049191A1 (ja) | 経口投与用医薬組成物 | |
| WO2013109225A1 (en) | Pharmaceutical tablet formulations comprising ceftibuten |